top of page

Idiopathic Intracranial Hypertension New Zealand

Our mission is to improve patient quality of life and prevent blindness from idiopathic intracranial hypertension (IIH)  through education, public awareness, support and research.

5
/100,000

annual risk of developing IIH

90
%

Female*

28 years

average age at diagnosis*

6
%

risk of surgery for treatment*

* Statistics based on New Zealand cohort

Prescription Drugs

New IIH Drug Trial

In Auckland, a clinical trial is available for patients NEWLY diagnosed with IIH who meet the eligibility criteria.

More information is found here

DALL·E 2023-06-24 16.12.30 - 3D render medical art describing idiopathic intracranial hype
Supportive Friend

Awareness Campaigns

September is IIH Awareness Month

This year, we are hoping to raise awareness, and we need your support. If you would like to be involved, please contact us.

icon WIX.jp2
landing-back.jpg

Our Purpose

We hope this support group brings patients together to a safe place where they can connect and support one another, informed by trusted professional health advice relevant to a NZ context. For a condition with more questions than answers, we aim to inform patients of up-to-date research and offer access to emerging treatments through clinical trials available in New Zealand. For healthcare providers we look to offer continuing education on IIH, to better inform, support and provide care for patients and whānau. Moreover, we also hope to enhance public awareness and research on this condition. 

Blog / News

Make a Donation

An Opportunity to Help

Please click on the link to Vision Research New Zealand and make a contribution by selecting IIH option.

bottom of page